Filing Details
- Accession Number:
- 0000711377-17-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-22 13:55:44
- Reporting Period:
- 2017-09-20
- Accepted Time:
- 2017-09-22 13:55:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189021 | Edward Bradley | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-20 | 22,200 | $36.07 | 83,712 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2017-09-20 | 11,400 | $39.61 | 95,112 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2017-09-20 | 5,276 | $47.12 | 81,274 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-20 | 38,876 | $71.28 | 61,512 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (Right to Buy) | Disposition | 2017-09-20 | 22,200 | $0.00 | 22,200 | $36.07 |
Common Stock | Common Stock (Right to Buy) | Disposition | 2017-09-20 | 11,400 | $0.00 | 11,400 | $39.61 |
Common Stock | Common Stock (Right to Buy) | Disposition | 2017-09-20 | 5,276 | $0.00 | 5,276 | $47.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
97,950 | 2018-08-30 | No | 4 | M | Direct | |
86,550 | 2019-10-31 | No | 4 | M | Direct | |
81,274 | 2020-11-08 | No | 4 | M | Direct |
Footnotes
- Options were granted August 30, 2013, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant
- Options were granted October 1, 2014, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
- Options were granted October 8, 2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant